Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary Pulmonary Hypertension.

Rich1

  • 1Rush Medical College, Rush-Presbyterian-St. Luke's Medical Center, 1725 West Harrison Street, Suite 020, Chicago, IL 60612, USA. PPH@rush.edu

Current Treatment Options in Cardiovascular Medicine
|November 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

To wait or to intubate?

JEMS : a journal of emergency medical services·2010
Same author

Skerra A, 2000. Engineered scaffolds for molecular recognition. Journal of Molecular Recognition13:167-187.

Journal of molecular recognition : JMR·2000
Same author

Evaluations of Outcome Sequences.

Organizational behavior and human decision processes·2000
Same author

Article reviewed: Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome.

Sleep medicine·2000
Same author

Implementing surface plasmon resonance biosensors in drug discovery.

Pharmaceutical science & technology today·2000
Same author

Irradiation Plus 5-Fluorouracil: Cellular Mechanisms of Action and Treatment Schedules.

Seminars in radiation oncology·2000
Same journal

An Update on the Role of Renal Artery Denervation in the Treatment of Hypertension.

Current treatment options in cardiovascular medicine·2026
Same journal

Advancements and Challenges in Contemporizing Care for Adult Patients with Congenital Heart Disease and Advanced Heart Failure: An Update on Application of Modern Heart Failure Technologies.

Current treatment options in cardiovascular medicine·2026
Same journal

Evolving Decongestion Strategies in the Management of Acute Heart Failure.

Current treatment options in cardiovascular medicine·2025
Same journal

Advanced Electroanatomic Mapping: Current and Emerging Approaches.

Current treatment options in cardiovascular medicine·2025
Same journal

Metabolic Reprogramming in Heart Failure: From Energy Starvation to Therapeutic Targets.

Current treatment options in cardiovascular medicine·2025
Same journal

Drug-Coated Balloons for Coronary Artery Disease: From Theory to Practice.

Current treatment options in cardiovascular medicine·2025
See all related articles

Primary pulmonary hypertension is now treatable with advanced therapies. Early diagnosis and specialized care, including anticoagulation and targeted treatments like calcium channel blockers or prostacyclin, improve outcomes, with lung transplantation as a final option.

Area of Science:

  • Cardiology
  • Pulmonology
  • Medical Therapy

Background:

  • Primary pulmonary hypertension (PPH) diagnosis requires thorough workup for unexplained right ventricular enlargement.
  • Recent medical therapy advances have made PPH a treatable condition.

Purpose of the Study:

  • To outline current therapeutic strategies for primary pulmonary hypertension.
  • To emphasize the importance of specialized care and individualized treatment plans.

Main Methods:

  • Review of current medical literature and treatment guidelines for PPH.
  • Case-by-case evaluation of therapeutic options.

Main Results:

  • Warfarin anticoagulation is generally recommended for all PPH patients.

Related Experiment Videos

  • Approximately 20% of patients respond well to high-dose calcium channel blockers.
  • Continuous intravenous prostacyclin therapy benefits the remaining patients.

    • Conclusions:

    • Patients with PPH should be referred to specialized centers for optimal management.
    • Medical therapy is effective, but lung transplantation remains an option for refractory cases.